Accelerate the upgrading and transformation for APIs
The API industry has entered the 3.0 era,it is neccessary to shift from traditional APIs to high-barrier specialty APIs,patented APIs, and biopharmaceutical raw materials. By overcoming more complex synthesis processes and meeting stricter regulatory standards, we aim to integrate into the global high-value pharmaceutical industry chain. This represents a crucial leap from “cost competition” to…


